Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The market size for GLP-1 Receptor Agonists is projected to reach USD 7.9 billion by 2036
Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial
Table 6 summarizes the studies with renal outcomes
Wegovy prior authorization criteria Even if a BCBS plan does offer coverage for Wegovy, patients must meet specific criteria before BCBS will help pay for this medication
US$ 22.24
US$ 27.52
US$ 25.00
